CELADON PHARMACEUTICALS PLC Logo

CELADON PHARMACEUTICALS PLC

CEL | IL

Overview

Corporate Details

ISIN(s):
GB00BDQYGP38
LEI:
213800YXCATORT475807
Country:
United Kingdom
Address:
32-33 COWCROSS STREET, EC1M 6DF LONDON
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Celadon Pharmaceuticals PLC is a vertically integrated pharmaceutical company focused on the research, cultivation, manufacturing, and commercial sale of cannabis-based medicines. The company's primary target market is chronic pain, aiming to provide alternatives to traditional treatments. It operates a licensed, 100,000 sq ft, EU-GMP certified facility for the indoor cultivation of high-THC cannabis and the extraction of Active Pharmaceutical Ingredients (API). A key differentiator is its MHRA-conditionally approved clinical trial for chronic pain, which seeks to generate robust data for potential reimbursement by national health services. Founded in 2018, Celadon is also engaged in R&D to generate novel intellectual property and develop a pipeline of prescription medicines for various conditions.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for CELADON PHARMACEUTICALS PLC. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-07-28 17:10
Post-Annual General Meeting Information
Result of General Meeting
English 20.4 KB
2025-07-02 08:00
Pre-Annual General Meeting Information
Proposed Cancellation
English 99.3 KB
2025-07-01 12:48
Capital/Financing Update
Funding Update
English 10.8 KB
2025-07-01 09:20
Post-Annual General Meeting Information
Result of AGM
English 24.0 KB
2025-06-30 08:00
Report Publication Announcement
Funding and Operational Update, Delay in Results
English 22.5 KB
2025-06-11 08:00
Capital/Financing Update
New Committed Credit Facility
English 14.2 KB
2025-06-06 16:55
Regulatory News Service
Funding Update, Notice of AGM
English 12.1 KB
2025-05-30 19:07
Capital/Financing Update
Funding Update
English 11.3 KB
2025-03-19 08:00
Capital/Financing Update
Funding Update
English 11.8 KB
2025-02-26 14:00
Capital/Financing Update
New Committed Credit Facility
English 15.5 KB
2025-02-12 08:00
Capital/Financing Update
Finance Update
English 10.4 KB
2025-01-31 08:00
Capital/Financing Update
Finance Update
English 10.7 KB
2025-01-16 08:00
Regulatory News Service
Update on Strategic Collaboration
English 13.7 KB
2025-01-02 08:00
Capital/Financing Update
Funding Update
English 10.6 KB
2024-12-20 08:00
Capital/Financing Update
Finance Update
English 10.8 KB

Automate Your Workflow. Get a real-time feed of all CELADON PHARMACEUTICALS PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for CELADON PHARMACEUTICALS PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK